Total Spend
R5288
Purchases
24
Avg CPRRED
R220
Target: R65
Avg ROASRED
2.6x
Target: 5x+
Scale Alert
Hold
👀 HOLD: Continue monitoring. Target CPR < R65 & ROAS > 5x not yet met.
6 Active Ads to Pause — CPR above R200
Image 3 - Copy 2,2 - HL 1,2 - 2026-03-24
CBO | TOF | Sales | 2026-03-11 → 25% PROMO - Women - Broad - All -2026-03-24
R1871 spentR267 CPR
Image 4- UC - Copy 5 - HL 4 - 2026-04-01
ABO | Retargeting A2C | Sales | 2026-04-01 → Checkout Hesitation Killer - Women - Broad - All -2026-04-01
R1282 spentR183 CPR
Image 4- CHK - Copy 3- HL 3 - 2026-04-01
ABO | Retargeting A2C | Sales | 2026-04-01 → Checkout Hesitation Killer - Women - Broad - All -2026-04-01
R531 spentR177 CPR
Image | ChatGPT | 2026-05-10 - 1
ABO | Testing | Sales | 2026-05 → TEST | Batch 01 | Bundle Offer | Women | 40-65 | 2026-05-04
R511 spentR170 CPR
From Dull To Radiant - 2026-05-16 - 1
ABO | Testing | Sales | 2026-05 → TEST | Batch 01 | Bundle Offer | Women | 40-65 | 2026-05-04
R339 spentR169 CPR
5M Protocol | 1x1 | Buy4Get1Free | 2026-05-04
ABO | Testing | Sales | 2026-05 → TEST | Batch 01 | Bundle Offer | Women | 40-65 | 2026-05-04
R114 spentR114 CPR
All Active Ads
24 active ads (last 7 days)
| Ad Name | Spend | CPR | ROAS | CTR | ATC | IC | Sales | Status |
|---|---|---|---|---|---|---|---|---|
Image 3 - Copy 2,2 - HL 1,2 - 2026-03-24 CBO | TOF | Sales | 2026-03-11 | R1871 | R267 | 2.5x | 2.8% | 49 | 19 | 7 | 🔴 Pause — CPR too high |
Image 4- UC - Copy 5 - HL 4 - 2026-04-01 ABO | Retargeting A2C | Sales | 2026-04-01 | R1282 | R183 | 2.9x | 3.5% | 52 | 26 | 7 | 🟡 Monitor — watch for 24h |
Image 4- CHK - Copy 3- HL 3 - 2026-04-01 ABO | Retargeting A2C | Sales | 2026-04-01 | R531 | R177 | 2.2x | 5.4% | 14 | 5 | 3 | 🟡 Monitor — watch for 24h |
Image | ChatGPT | 2026-05-10 - 1 ABO | Testing | Sales | 2026-05 | R511 | R170 | 2.3x | 3.6% | 34 | 14 | 3 | 🟡 Monitor — watch for 24h |
From Dull To Radiant - 2026-05-16 - 1 ABO | Testing | Sales | 2026-05 | R339 | R169 | 4.2x | 8.8% | 44 | 20 | 2 | 🟡 Monitor — watch for 24h |
5M Protocol | 1x1 | Buy4Get1Free | 2026-05-04 ABO | Testing | Sales | 2026-05 | R114 | R114 | 3.2x | 4.9% | 5 | 5 | 1 | 🟡 Monitor — watch for 24h |
Max Savings | 1x1 | Buy6Get2Free | 2026-05-10 - 3 ABO | Testing | Sales | 2026-05 | R109 | — | — | 2.9% | 5 | 1 | 0 | 👀 Monitor |
Image | ChatGPT | 2026-05-09 - 1 ABO | Testing | Sales | 2026-05 | R88 | — | — | 3.8% | 6 | 0 | 0 | 👀 Monitor |
Smart Buy | 1x1 | Buy4Get1Free | 2026-05-04 ABO | Testing | Sales | 2026-05 | R86 | R86 | 15.8x | 4.5% | 4 | 2 | 1 | ✅ Protect — strong performer |
Max Savings | 1x1 | Buy6Get2Free | 2026-05-04 ABO | Testing | Sales | 2026-05 | R69 | — | — | 5.9% | 9 | 2 | 0 | 👀 Monitor |
Image 2 - Copy 1,2 - HL 1,2 - 2026-03-24 CBO | TOF | Sales | 2026-03-11 | R60 | — | — | 2.0% | 0 | 1 | 0 | 👀 Monitor |
Best Value v1 | 1x1 | Buy4Get1Free | 2026-05-04 ABO | Testing | Sales | 2026-05 | R55 | — | — | 4.2% | 2 | 0 | 0 | 👀 Monitor |
Image | ChatGPT | 2026-05-09 - 2 ABO | Testing | Sales | 2026-05 | R37 | — | — | 4.2% | 4 | 0 | 0 | Insufficient data |
Videos | 10 | 2026-05-09 - 1 ABO | Testing | Sales | 2026-05 | R30 | — | — | 5.2% | 0 | 1 | 0 | Insufficient data |
Image 2- CHK - Copy 3- HL 3 - 2026-04-01 ABO | Retargeting A2C | Sales | 2026-04-01 | R27 | — | — | 7.7% | 1 | 1 | 0 | Insufficient data |
Image | ChatGPT | 2026-05-10 - 2 ABO | Testing | Sales | 2026-05 | R26 | — | — | 3.5% | 1 | 0 | 0 | Insufficient data |
Image | Higgs | 2026-05-09 - 1 ABO | Testing | Sales | 2026-05 | R21 | — | — | 4.6% | 4 | 0 | 0 | Insufficient data |
Image 1- CHK - Copy 3- HL 3 - 2026-04-01 ABO | Retargeting A2C | Sales | 2026-04-01 | R10 | — | — | 1.9% | 0 | 0 | 0 | Insufficient data |
From Dull To Radiant - 2026-05-16 - 2 ABO | Testing | Sales | 2026-05 | R8 | — | — | 5.3% | 3 | 2 | 0 | Insufficient data |
Image 3- CHK - Copy 3- HL 3 - 2026-04-01 ABO | Retargeting A2C | Sales | 2026-04-01 | R5 | — | — | 0.0% | 0 | 0 | 0 | Insufficient data |
From Dull To Radiant - 2026-05-16 - 3 ABO | Testing | Sales | 2026-05 | R4 | — | — | 8.1% | 0 | 0 | 0 | Insufficient data |
From Dull To Radiant - 2026-05-16 - 4 ABO | Testing | Sales | 2026-05 | R2 | — | — | 12.5% | 0 | 0 | 0 | Insufficient data |
From Dull To Radiant - 2026-05-16 - 6 ABO | Testing | Sales | 2026-05 | R2 | — | — | 0.0% | 0 | 0 | 0 | Insufficient data |
From Dull To Radiant - 2026-05-16 - 5 ABO | Testing | Sales | 2026-05 | R2 | — | — | 0.0% | 0 | 0 | 0 | Insufficient data |